Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Expanding repertoire of toxicities assocaited with therapeutic interventions

Anna Claire Olsson-Brown • 4 Jun 2022
ASCO 2022
General

Anna Claire Olsson-Brown, MBChB, The Clatterbridge Cancer Centre, Birkenhead, UK, touches on the expanding repertoire of toxicities associated with therapeutic interventions and highlights the importance of focusing on understanding adverse events. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Anna Claire Olsson-Brown

1:40
Impact of the COVID-19 pandemic on cancer services in the UK
Anna Claire Olsson-Brown • 4 Jun 2022
2:44
Association of pre-existing autoimmune disease & irAEs secondary to ICI therapy
Anna Claire Olsson-Brown • 4 Jun 2022
1:36
Optimizing the management of immune-related adverse events
Anna Claire Olsson-Brown • 4 Jun 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals